Searched for
PHARMACEUTICAL COMPANY
Sun Pharma gets ratings boost from Moody's, S&P over USD 11.75-bn Organon & Co acquisition bidRating agencies Moody's and S&P assigned investment-grade ratings to Sun Pharmaceutical Industries. This action follows Sun Pharma's propos...- Biocon shares rise 2% on 10-year Pertuzumab supply deal for breast cancer therapy in BrazilBiocon shares rose after the company secured a 10-year Pertuzumab supply contract in Brazil. The consortium with Bahiafarma and Bionovis re...
- Biocon signs 10-year Brazil supply deal for Pertuzumab breast cancer drugIn a significant move, Biocon has secured a ten-year contract in Brazil for the distribution of Pertuzumab, made possible through its colla...
- Supreme Court ruling: Company criminal liability upheld even without director indictment in cheating casesThe Supreme Court ruled criminal cases against companies can proceed without specific individuals named. This decision impacts corporate cr...
- Prasol Chemicals mobilises Rs 150 cr from anchor investors ahead of IPOPrasol Chemicals has raised nearly Rs 150 crore from anchor investors ahead of its Rs 500-crore IPO, which opens on September 8. The specia...
- 360 One Group CEO Bhagat buys 1.3 lakh shares of Novartis India for Rs 22 crKaran Bhagat acquired 1.3 lakh Novartis India shares for nearly Rs 22 crore. His firm Kyrush Investments sold an equal number of shares in ...
- Bharat Health Expo expected to be four times bigger in 2027, participation to rise six-fold: Piyush GoyalThe Bharat Health Global Expo is expected to grow substantially. Its next edition will be four times larger than the current one. Participa...
- Karnataka delegation heads to France, Netherlands to attract investmentsKarnataka's industries minister will lead a delegation to France and the Netherlands. This high-level team aims to attract global companies...
- Gland Pharma block deal: Fosun Pharma divests 99 lakh shares worth Rs 2,800 croreFosun Pharma sold a 6% stake in Gland Pharma for ₹2,800 crore via a block deal, reducing its holding to 45.77%. Major buyers included Kotak...
- Lupin gets USFDA approval for Modafinil tablets to treat excessive sleepinessPharmaceutical major Lupin announced its USFDA approval for Modafinil tablets. These tablets are used to treat excessive sleepiness in adul...
- Drug cos refuse to take sole responsibility for overpricingIndian drugmakers oppose a proposal making them solely liable for medicine overpricing. This regulatory move exempts retail chemists, hospi...
- Cohance Lifesciences to invest USD 18 mn in NJ Bio, Aruka BioCohance Lifesciences announced an eighteen million dollar investment to strengthen its antibody-drug conjugate strategy. This includes thir...
- Gland Pharma shares: Promoter Fosun Pharma likely to divest 5% equity worth Rs 2,279 crore via block dealFosun Pharma plans to divest 5% equity in Gland Pharma through a Rs 2,279.5 crore block deal at Rs 2,763 per share. Gland Pharma reported a...
- Sun Pharma agrees to lower US drug prices under Trump plan; analysts see limited financial impactSun Pharmaceutical Industries will offer its drugs at prices matching other developed nations. This agreement aims to make healthcare affor...
- Sun Pharma to extend MFN pricing to US state Medicaid programmesSun Pharma ranks second in US dermatology by prescriptions, with key brands including Ilumya for plaque psoriasis and Winlevi for acne. Rec...
- Sun Pharma among 9 pharmaceutical firms to lower drug prices for Americans, Trump saysNine pharmaceutical firms reached deals with the Trump administration for lower drug prices. These agreements expand the total number of co...
- Mankind Pharma divests entire stake in Broadway Hospitality to AKRK ProjectsMankind Pharma has completed the sale of its entire stake in Broadway Hospitality Services. The transaction involved transferring 100 perce...
- Aurobindo Pharma gains over 3% as subsidiary launches generic Advair Diskus in US; stock up 41% YTDAurobindo Pharma shares rose sharply after its subsidiary Lannett Company launched the generic equivalent of Advair Diskus in the US. The i...
- Argentina to ease pharma barriers as India trade tops $6.5 bnArgentina committed to reducing barriers for Indian pharmaceutical entry. This move will offer greater opportunities for Indian companies a...
- Huawei plans for more AI pharma tie-ups, says healthcare presidentThe move highlights Huawei's ambitions to gain a foothold in the fast-growing AI drug discovery market, where pharmaceutical companies are ...
Load More
